Pro Share Advisors LLC Arcturus Therapeutics Holdings Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$31.23 - $42.99 $189,378 - $260,691	6,064 New	6,064 $204,000
Q1 2022 May 10, 2022	SELL	$17.64 - $39.57 $146,800 - $329,301	-8,322 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$34.2 - $47.56 $239 - $332	-7 Reduced 0.08%	8,322 $308,000
Q3 2021 Nov 12, 2021	SELL	$27.88 - $58.25 $52,386 - $109,451	-1,879 Reduced 18.41%	8,329 $398,000
Q2 2021 Aug 13, 2021	BUY	$25.79 - $42.11 $32,392 - $52,890	1,256 Added 14.03%	10,208 $345,000
Q1 2021 May 14, 2021	BUY	$38.75 - $86.92 $11,470 - $25,728	296 Added 3.42%	8,952 $370,000
Q4 2020 Feb 09, 2021	BUY	$34.61 - $123.66 $299,584 - $1.07 Million	8,656 New	8,656 $375,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $439M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.